Core Insights - The article emphasizes the importance of generating alpha through independent investment strategies, focusing on sectors with perceived potential against the S&P 500 [1] - A generalist approach is adopted, allowing for exploration and investment across various sectors, with typical holding periods ranging from a few quarters to multiple years [1] Research Methodology - The company maintains comprehensive spreadsheets that track historical financial data, key metrics, guidance trends, and valuation comparisons against peers [1] - Monitoring includes not only company filings but also relevant industry news and reports, as well as analyses from other sources [1] - In instances of leadership changes, a deep dive into the new CEO's background and past performance is conducted to assess potential impacts on the company [1] Valuation Approach - The company rarely utilizes Discounted Cash Flow (DCF) models for long-term projections, believing they offer limited value [1] - Instead, the focus is on evaluating how a company has performed historically and the outlook on five key drivers of DCF valuation: revenues, costs and margins, cash flow conversion, capital expenditures, and interest rates [1]

Core Insights - The focus is on generating alpha through independent investment strategies, primarily managed via a Self Managed Super Fund [1] - The investment approach is generalist, analyzing various sectors with perceived alpha potential compared to the S&P 500 [1] - The typical investment holding period ranges from a few quarters to multiple years [1] Research Methodology - Comprehensive spreadsheets are maintained to track historical financial data, key metrics, guidance trends, and valuation comparisons with peers [1] - Monitoring includes industry news, reports, and other analysts' coverage, especially during significant events like CEO changes [1] - The emphasis is on assessing company performance and outlook based on five key drivers of DCF valuation rather than projecting long-term financials [1]

Company Overview - Edwards Lifesciences (NYSE: EW) is recognized as a high-quality company with a strong history of growth and high returns [1] - The company is a dominant player in the high-tech medical device segment, specifically providing solutions for structural heart patients [1] Market Performance - Share prices of Edwards Lifesciences have underperformed compared to the S&P 500 [1] Valuation Methodology - The company utilizes Cash Flow Returns On Investment based DCF valuation tools from ROCGA Research, which has over 20 years of experience in investment analysis [1] - ROCGA Research aims to identify undervalued and quality companies through an objective and systematic framework [1]

Core Insights - Intel Corporation has historically dominated the semiconductor industry, claiming to have "put the silicon in Silicon Valley" through its comprehensive in-house operations, which include design, development, manufacturing, and marketing of computing products and services [1] Group 1 - Intel's business model has been characterized by vertical integration, allowing the company to control all aspects of its product lifecycle [1] - The company is actively seeking undervalued and quality companies for investment opportunities, utilizing Cash Flow Returns On Investment based DCF valuation tools [1]